We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
Angus
Williams
angus.williams@cntw.nhs.uk
Schizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
One in three people with psychosis experience distressing visual hallucinations (VH) – seeing things that others cannot. When VH occur, they can have a detrimental impact on people’s lives, such as more frequent and prolonged hospital admissions, and greater likelihood of suicide.
A previous study by this team (The experience of VH in psychosis from the first-person perspective: IRAS ID: 291872) spoke to 12 people with VH. We found that the way in which people make sense of their VH are one of the keys factors driving distress. For example, when people thought VH were negative or threatening, they found them to be more distressing and this had a bigger impact on their lives. The next step is therefore to explore this on a larger scale to understand more about people’s appraisals of VH. Then this can be used to validate a scale of VH appraisals and develop targeted treatments for these.
To do so, this study will develop a questionnaire focused on people’s beliefs about VH. It will also explore the relationship of visions to other potential casual mechanisms such as poor sleep, and excessive worry.
900 people with psychosis will complete self-report questionnaires (approximately 30-45 minutes). After this, a subgroup of 100 participants will be asked to repeat some of the measures a week later to test if the appraisals measure is consistent.
We will recruit participants via the Clinical Research Network (CRN), which has research staff based in NHS Trusts nationwide. The study is funded by the National Institute of Health Research. Recruiting via the CRN is a method which has been successfully used by other research group, with minimal risks identified.
By developing a new measure and our knowledge of causal mechanisms of visions, it will be the next important steps to developing better treatments for these.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
- Insufficient English language to understand and complete questionnaires. - Visions as a result of organic disorders, brain injury or ONLY when under the influence of alcohol or substances.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Angus
Williams
angus.williams@cntw.nhs.uk
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
Dr
Charlotte
Aynsworth
charlotte.aynsworth@cntw.nhs.uk
The study is sponsored by CUMBRIA, NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST and funded by NIHR Academy .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 58033
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
